ClinicalTrials.govpublic full text
An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment
recurrent b-cell non-hodgkin lymphoma, recurrent follicular lymphoma, recurrent indolent adult non-hodgkin lymphoma, recurrent marginal zone lymphoma, refractory b-cell non-hodgkin lymphoma, refractory follicular lymphoma
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 28332 · SHA-256 17c3746fc8cd5ac2
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.